PAI-1 Inhibitor
Aging / Age-related Conditions
Phase 1Active
Key Facts
About Juvenescence
Juvenescence is a pioneering, clinical-stage biopharmaceutical company with a singular mission: to extend the healthy human lifespan by developing therapeutics that target the fundamental biology of aging. The company leverages a world-class R&D team with extensive drug development experience and employs AI-enabled platforms to accelerate and de-risk its pipeline. With a goal of having five medicines in Phase I or II trials by 2025, Juvenescence is positioning itself at the forefront of the rapidly emerging longevity therapeutics market, aiming to transform aging from a period of chronic disease to one of sustained health.
View full company profile